Evaluation of Neuroaxonal Loss Outside of Any Inflammation in Multiple Sclerosis by a Multimodal Study of the Visual Pathways Model

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Multiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system. The mechanisms of neuro-axonal loss remain incompletely elucidated. An acute demyelinating lesion will produce both immediate and delayed axonal loss. Immediate axonal loss is linked to the occurrence of axonal transection. Delayed axonal loss is the cause of axonal degeneration in progressive MS. Visual impairment is common in the disease (vision, oculomotricity, cognition). Through a longitudinal multimodal analysis of visual pathways, we would like to investigate physiopathological mechanisms leading to neurodegenerative process and visual impairment.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male and/or female participants in the VWIMS research project

• At least 18 years of age at the time of inclusion in VWIMS - II

• Patient having given written consent to participate in the study

• Socially insured patient

• Patient willing to comply with all study procedures and duration

Locations
Other Locations
France
Direction de la Recherche et de l'innovation (DRI) 6 rue Professeur Laguesse
RECRUITING
Lille
Contact Information
Primary
OUTTERYCK Olivier, PhD
olivier.outteryck@chru-lille.fr
03.20.44.64.69
Backup
COURTOIS Brigitte
DRS.PROMOTION@CHU-LILLE.FR
03.20.44.41.45
Time Frame
Start Date: 2025-01-24
Estimated Completion Date: 2026-04-24
Participants
Target number of participants: 64
Treatments
Other: Not applicable. No treatment will be compared.
During the same visit, we will perform OCT-angiography (10 minutes) and evaluate visual cognition with an eye-tracker (20 minutes)
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Lille

This content was sourced from clinicaltrials.gov